Skip to main content

Table 1 Preoperative characteristics of 188 patients with clinically high-risk localized and locally advanced prostate cancer

From: Robot-assisted radical prostatectomy in the treatment of patients with clinically high-risk localized and locally advanced prostate cancer: single surgeons functional and oncologic outcomes

Parameters

N = 188

Age, median (IQR), year

62.5 (51.0–79.0)

BMI, median (IQR), kg/m2

25.4 (23.6–29.5)

ASA score, median (IQR)

2.0 (1.0–2.0)

PSA, median (IQR), ng/ml

28.85 (11.5–150.8)

Prostate volume, median (IQR), cc

38.6 (23.5–110.0)

Biopsy Gleason score

 

 6

4 (2.1%)

 7

58 (30.9%)

 8

82 (43.6%)

 ≥ 9

44 (23.4%)

Clinical stage

 

 High-risk localized (≤ cT2c)

54 (28.7%)

 High-risk locally advanced

134 (71.3%)

  cT3a

72 (38.3%)

  ≥ cT3b

62 (33.0%)

  cN1

10 (5.3%)

SHIM score, median (IQR)

16.5 (7–24)

IPSS score, median (IQR)

14.5 (4–28)

Charlson comorbidity index

 

 0

148 (78.7%)

 1–2

35 (18.6%)

  ≥ 3

5 (2.7%)